Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Editorial [Hot Topic: Targeting Arterial Thrombosis - Current Concepts and Future Developments (Guest Editor: Florian Krotz)] promotion: free to download

Volume:7   Issue:10
Pp: 1231-1231
Florian Krotz
DOI: 10.2174/138945006778559201

Redox Modification of Platelet Glycoproteins

Volume:7   Issue:10
Pp: 1233-1241
D. W. Essex and M. Li
DOI: 10.2174/138945006778559193

The Many Antithrombotic Actions of Nitric Oxide

Volume:7   Issue:10
Pp: 1243-1251
Constantine Tziros and Jane E. Freedman
DOI: 10.2174/138945006778559111

G-protein Dependent Platelet Signaling - Perspectives for Therapy

Volume:7   Issue:10
Pp: 1253-1263
H. Shankar, B. Kahner and S. P. Kunapuli
DOI: 10.2174/138945006778559166

Phosphotyrosine Signaling in Platelets: Lessons for Vascular Thrombosis

Volume:7   Issue:10
Pp: 1265-1273
Janet L. K. Wee and Denise E. Jackson
DOI: 10.2174/138945006778559265

Cyclooxygenase Inhibition and Atherothrombosis

Volume:7   Issue:10
Pp: 1275-1284
Hae-Young Sohn and Florian Krotz
DOI: 10.2174/138945006778559102

Editorial [Hot Topic: Beyond Chemotherapy: Future Directions in Lymphoma Treatment (Guest Editor: Thomas Decker)] promotion: free to download

Volume:7   Issue:10
Pp: 1291-1291
Thomas Decker
DOI: 10.2174/138945006778559238

Radioimmunotherapy of Non-Hodgkins Lymphomas

Volume:7   Issue:10
Pp: 1293-1300
Bruce D. Cheson
DOI: 10.2174/138945006778559157

Immunotoxins in the Treatment of Hematologic Malignancies

Volume:7   Issue:10
Pp: 1301-1311
Robert J. Kreitman and Ira Pastan
DOI: 10.2174/138945006778559139

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

Volume:7   Issue:10
Pp: 1313-1327
Dirk Winkler, Hartmut Dohner and Stephan Stilgenbauer
DOI: 10.2174/138945006778559184

The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma

Volume:7   Issue:10
Pp: 1335-1340
P. Jost, C. Peschel and J. Ruland
DOI: 10.2174/138945006778559256

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

Volume:7   Issue:10
Pp: 1341-1347
Constantine S. Mitsiades, Nicholas Mitsiades, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson
DOI: 10.2174/138945006778559247

Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery

Volume:7   Issue:10
Pp: 1349-1359
Ingo Ringshausen, Christian Peschel and Thomas Decker
DOI: 10.2174/138945006778559210

Therapeutic Targeting of Apoptotic Pathways in Cancer

Volume:7   Issue:10
Pp: 1361-1369
Johannes Meiler and Martin Schuler
DOI: 10.2174/138945006778559175

Current status of Immunotherapy in B Cell Malignancies

Volume:7   Issue:10
Pp: 1371-1374
D. M. Kofler, C. Mayr and C.-M. Wendtner
DOI: 10.2174/138945006778559120